Taiwania Capital Management Corporation

Surglasses is a Taiwanese medical technology company specializing in the development and distribution of innovative surgical navigation and educational solutions. The company's patented technology is used in high-performance surgical systems and educational products, offering a cost-effective alternative to traditional surgical planning tools. Surglasses' products, including the CE-approved Foresee-X smart surgical glasses with Augmented Reality, and the Caduceus for spine surgical navigation with 3D Mixed Reality, aim to enhance surgery safety, precision, and efficiency. The company, certified with CE Mark, ISO-13485, and GMP, is committed to continuous R&D to meet the needs of surgeons, physicians, and patients, and to contribute to advancements in medical electronics and minimally invasive surgery.

TFBS Bioscience is a Contract Research Organization based in Taiwan that offers a variety of biological testing services. The company specializes in viral vector manufacturing for cell and gene therapy products, along with biosafety testing and product release testing for these therapies, vaccines, and other biologic products. Additionally, TFBS Bioscience provides cell bank characterization, viral clearance, bulk and lot release testing, assay development both in vitro and in vivo, clinical sample analysis, and cleaning validation for reusable medical devices. Through its comprehensive service offerings, TFBS Bioscience supports the advancement of biopharmaceutical development and ensures compliance with safety standards.

PharmaEssentia Corporation is a biopharmaceutical company based in Taipei, Taiwan, focused on the research, development, production, and sale of therapeutic products aimed at treating various human diseases. The company specializes in areas such as hematology, oncology, and infectious diseases, with a product portfolio that includes ropeginterferon alfa-2b for polycythemia vera and essential thrombocythemia, as well as an Anti-PD-1 antibody for cancer treatment. Additionally, PharmaEssentia has licensed the development of Oraxol for certain cancers and KX01 for skin conditions like psoriasis. The company also engages in drug research initiatives, including a collaboration with Axis Therapeutics for T Cell Receptor-T therapy. Established in 2003, PharmaEssentia continues to expand its pipeline of biologics and specialty pharmaceuticals.

SyneuRx International Taiwan is a biomedical company focused on developing treatments for central nervous system-related disorders, specifically schizophrenia, depression, and dementia. The company is engaged in the clinical development of several drug candidates, including SND-11, SND-12, and SND-13, with SND-13 currently in Phase IIb/III trials aimed at providing add-on therapy for schizophrenia. Through its research and development efforts, SyneuRx aims to address the significant unmet needs in mental health care, contributing to improved treatment options for patients suffering from these conditions.

Tripresso is an online travel agent based in Taipei, Taiwan, established in 2013. Initially, it focused on creating an online marketplace for package tour suppliers, such as Lions Travel and Richmond, while also developing a user-friendly search engine for customers to find suitable travel products. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, the company introduced TripSaaS, a proprietary software-as-a-service system designed to assist traditional travel agencies in managing their websites, product listings, orders, and customer relationships, thereby improving operational efficiency. By leveraging data and partnerships from both online and offline sources, Tripresso aims to streamline travel planning and provide users with affordable travel packages.

Dcard is a social networking platform founded in 2015 and based in Taipei, Taiwan. It serves as the largest anonymous communication platform in the country, specifically designed to connect students within the campus community. Dcard allows users to share ideas and experiences freely, fostering a comfortable and trustworthy environment for interaction. The platform emphasizes inclusivity, enabling individuals from diverse backgrounds, ages, and interests to participate in discussions and exchanges without the constraints of identity.

Metanoia Communications Inc., established in 2004 and based in Hsinchu City, Taiwan, specializes in the development of semiconductor and software solutions for the wireline broadband and in-home networking markets. The company manufactures high-speed PHY chipsets, including products for VDSL2, G.fast, and G.hn technologies. With a focus on state-of-the-art system architecture and algorithm expertise, Metanoia delivers a diverse range of fixed-line communication products designed to meet the needs of broadband manufacturers. As a subsidiary of ELAN Microelectronics Corporation, Metanoia combines extensive integrated circuit design capabilities with innovative technology to support the growing demand for high-speed broadband connectivity.

Tripresso is an online travel agent based in Taipei, Taiwan, established in 2013. Initially, it focused on creating an online marketplace for package tour suppliers, such as Lions Travel and Richmond, while also developing a user-friendly search engine for customers to find suitable travel products. Over time, Tripresso expanded its offerings to include hotels, flight tickets, and customized travel plans for outbound travel. In 2018, the company introduced TripSaaS, a proprietary software-as-a-service system designed to assist traditional travel agencies in managing their websites, product listings, orders, and customer relationships, thereby improving operational efficiency. By leveraging data and partnerships from both online and offline sources, Tripresso aims to streamline travel planning and provide users with affordable travel packages.